Amyloid Beta-directed Antibody [EPC]

442 reported adverse events

Drugs of this class: ADUCANUMAB

These side effects are most commonly reported by patients taking drugs of the Amyloid Beta-directed Antibody [EPC] class:

# Side effect Count
0 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 110
1 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 69
2 HEADACHE 49
3 CONFUSIONAL STATE 33
4 CEREBRAL HAEMORRHAGE 26
5 DEMENTIA ALZHEIMER^S TYPE 19
6 FALL 19
7 DIZZINESS 17
8 SEIZURE 17
9 FATIGUE 16
See all common reactions for Amyloid Beta-directed Antibody [EPC]

Drugs of the Amyloid Beta-directed Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 69 0.8734
1 AMYLOID RELATED IMAGING ABNORMALITIES 8 0.5714
2 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 9 0.2812
3 CEREBRAL HAEMOSIDERIN DEPOSITION 1 0.0667
4 CEREBELLAR MICROHAEMORRHAGE 1 0.0556
5 WEST NILE VIRUS TEST POSITIVE 1 0.0417
6 CEREBRAL MICROHAEMORRHAGE 7 0.0372
7 COMPLICATED FRACTURE 1 0.0192
8 PANCREATIC ENZYME ABNORMALITY 1 0.0132
9 NEUROBORRELIOSIS 1 0.0106
See all enriched reactions for Amyloid Beta-directed Antibody [EPC]